MAP1LC3B and non-small cell lung carcinoma: We found that TMZ-POH treatment increased intracellular autophagosomes compared to its individual constituents and their combination, as demonstrated by accumulation of LC3B-positive spot-like structures in above drug treated four NSCLC cells (Fig. 1b).